Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $142.97 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $53.16 | 3 | $0 (2024) |
| PFIZER INC. | $51.72 | 4 | $0 (2022) |
| ABBVIE INC. | $38.09 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35.17 | 2 | AstraZeneca Pharmaceuticals LP ($35.17) |
| 2023 | $17.99 | 1 | AstraZeneca Pharmaceuticals LP ($17.99) |
| 2022 | $35.75 | 3 | PFIZER INC. ($23.83) |
| 2021 | $54.06 | 3 | PFIZER INC. ($27.89) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Respiratory | ||||||
| 01/27/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Respiratory | ||||||
| 08/16/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/08/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: NEUROSCIENCE | ||||||
| 07/21/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/10/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: VACCINES | ||||||
| 09/18/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/15/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
About Dr. Austin Yang, DO
Dr. Austin Yang, DO is a Internal Medicine healthcare provider based in Jbsa Ft Sam Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2019. The National Provider Identifier (NPI) number assigned to this provider is 1831650076.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Austin Yang, DO has received a total of $142.97 in payments from pharmaceutical and medical device companies, with $35.17 received in 2024. These payments were reported across 9 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($142.97).
Practice Information
- Specialty Internal Medicine
- Location Jbsa Ft Sam Houston, TX
- Active Since 03/29/2019
- Last Updated 02/03/2026
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1831650076
Products in Payments
- ELIQUIS (Drug) $39.79
- FASENRA (Biological) $35.17
- UBRELVY (Drug) $26.17
- BRILINTA (Drug) $17.99
- PREVNAR 20 (Biological) $11.93
- QULIPTA (Drug) $11.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Jbsa Ft Sam Houston
Dr. David Dulaney, Md, MD
Internal Medicine — Payments: $32,150
Dr. Wilfred Dela Cruz, Md, MD
Internal Medicine — Payments: $2,721
Dr. Charles Lin, Md, MD
Internal Medicine — Payments: $2,679
Michael Gonzales, M.d, M.D
Internal Medicine — Payments: $898.41
Dr. Johanna Hollweg, D.o, D.O
Internal Medicine — Payments: $614.63
Dr. Oscar Gallardo-Huizar, Md, MD
Internal Medicine — Payments: $479.02